Masanori Fukazawa

Structural basis for GLP-1 receptor activation by LY3502970, an orally active nonpeptide agonist

Takahiro Kawai, Bingfa Sun, Hitoshi Yoshino et al. · Proceedings of the National Academy of Sciences · 2020 · 172 citations · Full text

Tofogliflozin, a Potent and Highly Specific Sodium/Glucose Cotransporter 2 Inhibitor, Improves Glycemic Control in Diabetic Rats and Mice

Masayuki Suzuki, Kiyofumi Honda, Masanori Fukazawa et al. · Journal of Pharmacology and Experimental Therapeutics · 2012 · 164 citations

Tofogliflozin Improves Insulin Resistance in Skeletal Muscle and Accelerates Lipolysis in Adipose Tissue in Male Mice

Atsushi Obata, Naoto Kubota, Tetsuya Kubota et al. · Endocrinology · 2015 · 144 citations · Full text

Nutrition, Metabolic Disorder, Caloric Restriction +23

Tofogliflozin, a sodium/glucose cotransporter 2 inhibitor, attenuates body weight gain and fat accumulation in diabetic and obese animal models

M. Suzuki, Minako Takeda, A Kito et al. · Nutrition and Diabetes · 2014 · 97 citations · Full text

Tofogliflozin, a novel sodium–glucose co‐transporter 2 inhibitor, improves renal and pancreatic function in <i>db/db</i> mice

Takumi Nagata, Taku Fukuzawa, Minako Takeda et al. · British Journal of Pharmacology · 2013 · 87 citations · Full text